Physician

Suresh Kumar Srinivasan, M.D

According to 2025 Medicare claims, Suresh Srinivasan, M.D (NPI: 1346672268) practices pain management in the Weirton-Steubenville, WV-OH market, with the plurality of this provider's patient population coming from Jefferson, OH. This provider's primary affiliated billing organization is TRINITY WEST (NPI: 1043234677; TIN: 34-0875691) and primary practice location at 43952-2307.

Srinivasan's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 358 traditional Medicare patients, billed 2,976 HCPCS/CPT codes, and received $113,845 in Medicare payments. The top billing code was 99204 (New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more). Part D data shows 4,069 prescription claims across 589 beneficiaries totaling $354,244 in drug costs, led by Qutenza (Capsaicin/Skin Cleanser). DME data shows 241 claims. Open Payments data shows 62 records totaling $2,171. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing did not follow a clear longitudinal pattern. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $147 to $354,244. In contrast, DME billing represents a smaller volume and moved up and down with repeated peaks and valleys, starting at $331 and ending at $5,454.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	132	322	$27,776
2020	344	1,392	$107,104
2021	353	1,692	$129,541
2022	365	1,714	$124,621
2023	426	1,791	$132,718
2024	358	2,976	$113,845

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	12	18	$147
2019	142	498	$14,699
2020	416	2,301	$128,502
2021	473	2,488	$210,063
2022	560	3,285	$279,776
2023	653	4,441	$393,964
2024	589	4,069	$354,244

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	16	22	$179
2020	247	462	$16,242
2021	116	414	$10,020
2022	164	501	$15,779
2023	125	289	$10,808
2024	101	241	$5,454

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99204	New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more	52	52	$125
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	252	588	$84
62323	Injection of substance into lower spine canal using imaging guidance	60	66	$73
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	143	214	$57
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	104	151	$12

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Qutenza	Capsaicin/Skin Cleanser	30	2,510	$106,392
Belbuca	Buprenorphine Hcl	86	2,520	$64,119
Xtampza Er	Oxycodone Myristate	63	1,890	$28,866
Buprenorphine	Buprenorphine	85	2,380	$19,448
Lidocaine	Lidocaine	153	4,527	$12,757

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
A4595	Electrical stimulator supplies, 2 lead, per month, (e.g., tens, nmes)	N	39	157	$3,065
E0730	Transcutaneous electrical nerve stimulation (tens) device, four or more leads, for multiple nerve stimulation	N	18	18	$1,531
A4557	Lead wires, (e.g., apnea monitor), per pair	N	22	27	$534
E0730	Transcutaneous electrical nerve stimulation (tens) device, four or more leads, for multiple nerve stimulation	Y	22	39	$323

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	62	$2,171	Boston Scientific Corporation
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Suresh Kumar Srinivasan, M.D?

Tedicare shows public-source Medicare data for Suresh Kumar Srinivasan, M.D (NPI 1346672268), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Suresh Kumar Srinivasan, M.D have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Suresh Kumar Srinivasan, M.D?

Suresh Kumar Srinivasan, M.D is linked to TRINITY WEST (billing NPI 1043234677) in the available physician profile data.

Does Suresh Kumar Srinivasan, M.D have Open Payments data?

Suresh Kumar Srinivasan, M.D has 62 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.